Sinovac Biotech logo

SVA - Sinovac Biotech News Story

$6.47 0.0  0.0%

Last Trade - 22/02/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £188.1m
Position in Universe th / 6851

UPDATE 1-Brazil's Butantan to seek trials of COVID-19 vaccine Butanvac, Sao Paulo governor says

Fri 26th March, 2021 12:04pm
(Updates with governor, Butantan quotes)
    By Eduardo Simões
    SAO PAULO, March 26 (Reuters) - Brazil's Butantan biomedical
institute has developed a potential COVID-19 vaccine and later
today will ask for regulatory approval to begin human trials,
Sao Paulo governor Joao Doria told journalists on Friday.
    Butantan expects to start production in May to produced this
vaccine on a large scale. Mass vaccination would start in July.
    Butantan plans to test the vaccine on 1,800 volunteers over
two phases, two sources told Reuters earlier.
    The vaccine will be 100% developed in Brazil by an
international consortium. Vietnam and Thailand are part of the
consortium.
    Butantan already produces the Coronavac vaccine developed by
China's Sinovac and has delivered 27.8 million doses to the
Brazilian government.
    Doria said the new vaccine will not interfere in Butantan's
agreement with Sinovac and will be produced in a different
plant.

 (Reporting by Eduardo Simoes, writing by Carolina Mandl)
 ((carolina.mandl@thomsonreuters.com; +55 11 5644 7703; +55 11
97116-3806;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.